Denosumab in the treatment of delayed hypercalcemia after rhabdomyolysis
Background/objective: Rhabdomyolysis-associated hypercalcemia has limited management options in oliguric patients. Our objective is to describe a case of refractory rhabdomyolysis-associated hypercalcemia with concomitant anuria that was treated with denosumab. Case presentation: A 57-year-old woman...
| Published in: | Journal of Clinical and Translational Endocrinology Case Reports |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214624525000127 |
